Denali Therapeutics Inc.
$24.00
-0.67 (-2.72%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -1.4%
- 3 Months
- +14.1%
- YTD
- +45.4%
- 1 Year
- +53.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 56.6%
- Largest decline max drawdown, since Aug 2025
- -20.5%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.04
Own DNLI?
See how DNLI contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.